Nicholas was a Scientist at Juvena Therapeutics working in discovery and pre-clinical research from computational biology leads on regenerative therapeutics for neuromuscular diseases (i.e., sarcopenia, Alzheimer's, Parkinson's) and aging. He currently is an Investigator at Scribe Therapeutics, a molecular engineering company founded by CRIPSR inventors and working on in vivo therapies to treat disease.

  • PhD (2019-2020)